EGFR and cancer: Numerous studies have shown that EGFR and its downstream signals are overactivated in various cancer cell lines, but not in normal cells, suggesting that 2D5 peptide with high sequence specificity is preferentially cytotoxic against EGFR-overactivated cells (7, 11).